# Office Properties Income Trust of beneficial interest (OPI) fundamentals

Data as of 2026-11-10. NASDAQ, United States. Sector: Real Estate / Office REITs. Price $16.50, market value $362 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Office Properties Income Trust of beneficial interest reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.9×**. Each dollar of revenue is priced at 0.9×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.4×**. The shares trade at 1.4× book value; book value is a meaningful part of the valuation.

## Profitability
- **Net margin: -61.5%**. The company reported a net loss over the last twelve months.
- **Return on equity: -30.9%**. Return on equity is negative because earnings are negative.
- **Return on assets: -30.6%**. Each dollar of assets produces -30.6% of profit.

## Growth
- **Revenue growth (1 yr): -11.8%**. Revenue fell 11.8% over the last year.
- **EPS growth (1 yr): -44.1%**. Earnings per share fell 44.1%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 2.73**. Debt is 2.73 times equity, a leveraged balance sheet, which is normal for real estate.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Office Properties Income Trust of beneficial interest does not currently pay a dividend, but it returned 0.0% of its market value through buybacks over the last year.

## Price and momentum
- **From 52-week high: -66.8%** (39.9% above the low). Trading 67% below its 52-week high, deep in a drawdown.
- **RSI (14-day): 48**. An RSI of 48 is neutral.
- **Beta (1 yr): 1.58** (volatility 98%). Beta of 1.58 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OPI · Page: https://foliofundamentals.com/stocks/opi

Not investment advice.